
    
      This is a phase III single-dose, randomized , placebo and dose-controlled study to evaluate
      the safety and efficacy of a RX0041-002 topical solution for local anesthesia during
      diagnostic procedures and surgeries on or through the mucous membranes of the nasal cavities
      (e.g. nasal/sinus endoscopy, sinusotomy, fracture nasal turbunate(s), lysis intranasal
      synechia, insertion of nasal septal prosthesis, biopsy intranasal, excision of nasal polyps,
      excision turbinate(s), removal of foreign body intranasal, septoplasty, sinus debridement).
    
  